Therapeutic Potential of Melatonin, Erythropoietin, and TRPV4 Antagonism in a Preclinical Model of Genetic Hydrocephalus
Fatemeh Omidi Bidgoli, David Audu, Gowthami Mahendran, Yanping Zhang, Lauren Jantzie, Robinson Shenandoah, Bonnie Blazer-Yost
This study evaluates a triple therapy of erythropoietin, melatonin, and TRPV4 antagonist in a rat model of congenital hydrocephalus, showing reduced ventricular expansion and inflammation.
bioRxiv · Nov 6, 2026 · PreprintNeuroscience